Join James Chandler, VP Corporate Affairs to discuss what is next for UK industrial innovation from existing strengths, emerging trends to key cross-sector enablers
Meet Jérôme Pesenti, CEO BenevolentTech at Viva Technology in Paris
Making science personal. Bringing together big pharma, big data and healthcare providers.
Solving the world’s most pressing challenges through open innovation and partnership.
Only 1 in 5,000 medicines in development make it to market, with a drug typically taking 12 years to develop from initial discovery to market. Estimates vary but the Association of the British Pharmaceutical Industry puts drug development at £1.15bn per drug.
Celebrate the establishment of the first international ChIPs Chapter on Thursday, 27 April 2017 from 5:30PM to 9:00PM at the Supreme Court building, London, United Kingdom. The festivities will include a panel discussion bringing together women leaders from the UK and US, followed by a reception.
Meet Ken Mulvany at Rutberg Summit presenting BenevolentAI's work on Artificial Intelligence applied to drug discovery
BenevolentAI Team will be attending the event, get in touch!